217 related articles for article (PubMed ID: 32992915)
1. Impact of HLA-DR Antigen Binding Cleft Rigidity on T Cell Recognition.
Szeto C; Bloom JI; Sloane H; Lobos CA; Fodor J; Jayasinghe D; Chatzileontiadou DSM; Grant EJ; Buckle AM; Gras S
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32992915
[TBL] [Abstract][Full Text] [Related]
2. Structural analysis of two HLA-DR-presented autoantigenic epitopes: crucial role of peripheral but not central peptide residues for T-cell receptor recognition.
De Oliveira DB; Harfouch-Hammoud E; Otto H; Papandreou NA; Stern LJ; Cohen H; Boehm BO; Bach J; Caillat-Zucman S; Walk T; Jung G; Eliopoulos E; Papadopoulos GK; van Endert PM
Mol Immunol; 2000 Oct; 37(14):813-25. PubMed ID: 11257303
[TBL] [Abstract][Full Text] [Related]
3. Characterization of HLA-DR- and TCR-binding residues of an immunodominant and genetically permissive peptide of the 16-kDa protein of Mycobacterium tuberculosis.
Caccamo N; Meraviglia S; La Mendola C; Bosze S; Hudecz F; Ivanyi J; Dieli F; Salerno A
Eur J Immunol; 2004 Aug; 34(8):2220-9. PubMed ID: 15259019
[TBL] [Abstract][Full Text] [Related]
4. Human leukocyte antigen (HLA) class II peptide flanking residues tune the immunogenicity of a human tumor-derived epitope.
MacLachlan BJ; Dolton G; Papakyriakou A; Greenshields-Watson A; Mason GH; Schauenburg A; Besneux M; Szomolay B; Elliott T; Sewell AK; Gallimore A; Rizkallah P; Cole DK; Godkin A
J Biol Chem; 2019 Dec; 294(52):20246-20258. PubMed ID: 31619516
[TBL] [Abstract][Full Text] [Related]
5. Specificity of bispecific T cell receptors and antibodies targeting peptide-HLA.
Holland CJ; Crean RM; Pentier JM; de Wet B; Lloyd A; Srikannathasan V; Lissin N; Lloyd KA; Blicher TH; Conroy PJ; Hock M; Pengelly RJ; Spinner TE; Cameron B; Potter EA; Jeyanthan A; Molloy PE; Sami M; Aleksic M; Liddy N; Robinson RA; Harper S; Lepore M; Pudney CR; van der Kamp MW; Rizkallah PJ; Jakobsen BK; Vuidepot A; Cole DK
J Clin Invest; 2020 May; 130(5):2673-2688. PubMed ID: 32310221
[TBL] [Abstract][Full Text] [Related]
6. Sulfamethoxazole induces a switch mechanism in T cell receptors containing TCRVβ20-1, altering pHLA recognition.
Watkins S; Pichler WJ
PLoS One; 2013; 8(10):e76211. PubMed ID: 24116097
[TBL] [Abstract][Full Text] [Related]
7. Predicting CD4 T-cell epitopes based on antigen cleavage, MHCII presentation, and TCR recognition.
Schneidman-Duhovny D; Khuri N; Dong GQ; Winter MB; Shifrut E; Friedman N; Craik CS; Pratt KP; Paz P; Aswad F; Sali A
PLoS One; 2018; 13(11):e0206654. PubMed ID: 30399156
[TBL] [Abstract][Full Text] [Related]
8. Flexibility in T-cell receptor ligand repertoires depends on MHC and T-cell receptor clonotype.
Geluk A; van Meijgaarden KE; Ottenhoff TH
Immunology; 1997 Mar; 90(3):370-5. PubMed ID: 9155643
[TBL] [Abstract][Full Text] [Related]
9. Implication of HLA-DR residues at positions 67, 71, and 86 in interaction between HLA-DR11 and peptide HA306-320.
Zeliszewski D; Golvano JJ; Gaudebout P; Dorval I; Freidel C; Gebuhrer L; Betuel H; Borras-Cuesta F; Sterkers G
J Immunol; 1993 Dec; 151(11):6237-47. PubMed ID: 7504016
[TBL] [Abstract][Full Text] [Related]
10. Structural basis of specificity and degeneracy of T cell recognition: pluriallelic restriction of T cell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor, peptide, and HLA-DR.
Doherty DG; Penzotti JE; Koelle DM; Kwok WW; Lybrand TP; Masewicz S; Nepom GT
J Immunol; 1998 Oct; 161(7):3527-35. PubMed ID: 9759873
[TBL] [Abstract][Full Text] [Related]
11. Functional interaction between human T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen.
Gay D; Maddon P; Sekaly R; Talle MA; Godfrey M; Long E; Goldstein G; Chess L; Axel R; Kappler J
Nature; 1987 Aug 13-19; 328(6131):626-9. PubMed ID: 3112582
[TBL] [Abstract][Full Text] [Related]
12. Characterization of HLA class II/peptide-TCR interactions of the immunodominant T cell epitope in Art v 1, the major mugwort pollen allergen.
Jahn-Schmid B; Sirven P; Leb V; Pickl WF; Fischer GF; Gadermaier G; Egger M; Ebner C; Ferreira F; Maillére B; Bohle B
J Immunol; 2008 Sep; 181(5):3636-42. PubMed ID: 18714038
[TBL] [Abstract][Full Text] [Related]
13. Magnitude of structural changes of the T-cell receptor binding regions determine the strength of T-cell antagonism: molecular dynamics simulations of HLA-DR4 (DRB1*0405) complexed with analogue peptide.
Toh H; Kamikawaji N; Tana T; Muta S; Sasazuki T; Kuhara S
Protein Eng; 2000 Jun; 13(6):423-9. PubMed ID: 10877853
[TBL] [Abstract][Full Text] [Related]
14. A new type of metal recognition by human T cells: contact residues for peptide-independent bridging of T cell receptor and major histocompatibility complex by nickel.
Gamerdinger K; Moulon C; Karp DR; Van Bergen J; Koning F; Wild D; Pflugfelder U; Weltzien HU
J Exp Med; 2003 May; 197(10):1345-53. PubMed ID: 12756270
[TBL] [Abstract][Full Text] [Related]
15. ZAP-70 and p72syk are signaling response elements through MHC class II molecules.
Kanner SB; Grosmaire LS; Blake J; Schieven GL; Masewicz S; Odum N; Ledbetter JA
Tissue Antigens; 1995 Sep; 46(3 ( Pt 1)):145-54. PubMed ID: 8525473
[TBL] [Abstract][Full Text] [Related]
16. CD4
Galperin M; Farenc C; Mukhopadhyay M; Jayasinghe D; Decroos A; Benati D; Tan LL; Ciacchi L; Reid HH; Rossjohn J; Chakrabarti LA; Gras S
Sci Immunol; 2018 Jun; 3(24):. PubMed ID: 29884618
[TBL] [Abstract][Full Text] [Related]
17. A molecular basis for the T cell response in HLA-DQ2.2 mediated celiac disease.
Ting YT; Dahal-Koirala S; Kim HSK; Qiao SW; Neumann RS; Lundin KEA; Petersen J; Reid HH; Sollid LM; Rossjohn J
Proc Natl Acad Sci U S A; 2020 Feb; 117(6):3063-3073. PubMed ID: 31974305
[TBL] [Abstract][Full Text] [Related]
18. Amino acid substitutions in the putative MHC class II "dimer of dimers" interface inhibit CD4+ T cell activation.
Lindstedt R; Monk N; Lombardi G; Lechler R
J Immunol; 2001 Jan; 166(2):800-8. PubMed ID: 11145653
[TBL] [Abstract][Full Text] [Related]
19. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta.
Flament C; Benmerah A; Bonneville M; Triebel F; Mami-Chouaib F
J Immunol; 1994 Oct; 153(7):2890-904. PubMed ID: 8089476
[TBL] [Abstract][Full Text] [Related]
20. Extraordinary cross-reactivity of an autoimmune T-cell receptor recognizing specific peptides both on autologous and on allogeneic HLA class II molecules.
Hansen BE; Rasmussen AH; Jakobsen BK; Ryder LP; Svejgaard A
Tissue Antigens; 2007 Jul; 70(1):42-52. PubMed ID: 17559580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
